Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Malmo-based Swedencare has opened a sales and marketing subsidiary based in Barcelona.
Covenant Animal Health Partners has commenced its first R&D projects as it aims to revolutionize the innovation route in animal health.
Phytogenic feed additive specialist Delacon has opened a new office in Singapore and expanded its team in Asia with two new appointments.
Virbac believes it will record sales growth of 4-6% at constant exchange rates in 2019.
The European Medicines Agency (EMA) has officially moved in to its new location in Amsterdam, the Netherlands, after leaving its London premises on March 1, 2019.
Elanco has become a standalone player in the animal health sector after finalizing its exit from Eli Lilly.
Eli Lilly has extended its offer for shareholders to exchange their shares of the firm's stock for shares of Elanco and announced the final exchange ratio for the offer.
French firm Dômes Pharma has benefitted from adopting a multi-channel approach to selling its companion animal products since 2012. Animal Pharm editor Joseph Harvey spoke to the company's president Anne Chauder about how Dômes has balanced R&D with being an online wholesaler.
Kemin Industries has made an investment in a Chinese animal nutrition company to develop its fermentation and production capabilities in the region.
US veterinary diagnostics firm Heska has witnessed its share price drop after posting poor fourth-quarter results for 2018.
AdvaVet will submit a listing prospectus to the US Securities and Exchange Commission (SEC) in March for review and approval.
Boehringer Ingelheim has launched an online store for its companion animal parasiticide products in China.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.